Characterization and release behaviors of porous PCL/Eudragit RS microcapsules containing tulobuterol

Colloids and Surfaces B: Biointerfaces

Volumn 76, Issue 2, 2010, Pages 404-409

  Kim, Ki Seok ^a   Park, Soo Jin ^a  

^a Inha University   (South Korea)

Author keywords

Eudragit RS; Poly( caprolactone); Porous microcapsules; Release behaviors

Indexed keywords

CAPROLACTONE; CARBOXYL GROUPS; DIFFUSION RATE; DRUG LOADING; DRUG RELEASE; ENCAPSULATION EFFICIENCY; EUDRAGIT; MICROCAPSULES; MODEL DRUGS; POROUS MICROCAPSULES; QUATERNARY AMMONIUM GROUP; RELEASE BEHAVIORS; RELEASE RATE; SMOOTH SURFACE; SOLVENT EVAPORATION METHOD;

AMMONIUM COMPOUNDS; DRUG INTERACTIONS; RAPID SOLIDIFICATION;

ENCAPSULATION;

CARBOXYL GROUP; EUDRAGIT; EUDRAGIT RS; POLYCAPROLACTONE; QUATERNARY AMMONIUM DERIVATIVE; TULOBUTEROL;

ARTICLE; CONTROLLED STUDY; DRUG DIFFUSION; DRUG FORMULATION; DRUG RELEASE; ENCAPSULATION; EVAPORATION; HYDRATION; IN VITRO STUDY; MICROCAPSULE; MOLECULAR INTERACTION; PARTICLE SIZE; POROSITY; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

ACRYLIC RESINS; CAPSULES; PARTICLE SIZE; POLYESTERS; POROSITY; SOLUBILITY; SURFACE PROPERTIES; TERBUTALINE;

EID: 75749134041     PISSN: 09277765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2009.11.015     Document Type: Article

References (21)

1. Radt B., Smith T.A., and Caruso F. Adv. Mater. 16 (2004) 2184
2. Song S.W., and Hidajat K. Langmuir 21 (2005) 9568
3. Park S.J., Yang Y.J., and Lee H.B. Colloid Surf. B 38 (2005) 35
4. Mastiholimath V.S., Dandagi P.M., Gadad A.P., Mathews R., and Kulkarni A.R. J. Microencapsul. 25 (2008) 307
5. Eldsater C., Erlandsson B., Renstad R., Albertsson A.C., and Karlsson S. Polymer 41 (2000) 1297
6. Park S.J., Kim K.S., and Kim S.H. Colloid Surf. B 43 (2005) 238
7. Coombes A.G.A., Rizzi S.C., Williamson M., Barralet J.E., Downes S., and Wallace W.A. Biomaterials 25 (2004) 315
8. Prabu P., Kim K.W., Dharmaraj N., Park J.H., Khil M.S., and Kim H.Y. Macromol. Res. 16 (2008) 303
9. Pignatello R., Amico D., Chiechio S., Giunchedi P., Spadaro C., and Puglisi G. Drug Deliv. 8 (2001) 35
10. de Oliveiraa H.P., Albuquerque Jr. J.J.F., Nogueirasa C., and Rieumonta J. Int. J. Pharm. 366 (2009) 185
11. Siepmann F., Siepmann J., Walther M., MacRae R.J., and Bodmeier R. J. Control. Release 125 (2008) 1
12. Quinteros D.A., Rigo V.R., Kairuz A.F.J., Oliveira M.E., Manzo R.H., and Allemandi D.A. Eur. J. Pharm. Sci. 33 (2008) 72
13. Narisawa S., Nagata M., Hirakawa Y., Kobayashi M., and Yoshino H. J. Pharm. Sci. 85 (1996) 184
14. Ubrich N., Schmidt C., Bodmeier R., Hoffman M., and Maincent P. Int. J. Pharm. 288 (2005) 169
15. Park S.J., Cho K.S., and Ryu S.K. Carbon 41 (2003) 1437
16. Takasu M., Shiroya T., Takeshita K., Sakamoto M., and Kawaguchi H. Colloid Polym. Sci. 282 (2003) 119
17. Huang C.Y., Chen C.M., and Lee Y.D. Int. J. Pharm. 338 (2007) 267
18. J. Kreuter, Nanoparticles. In: J. Kreuter (Ed.), Colloidal Drug Delivery Systems, vol. 66, Marcel Dekker Inc., New York, 1994, pp. 219-342.
19. Armand J.Y., Magnard F., Bozon H., Rollet J., Taverdet J.L., and Vergnaud J.M. Int. J. Pharm. 40 (1987) 33
20. Martin A., Swarbrick J., and Cammarata A. Physical Pharmacy. 3rd ed. (1983), Lea & Febiger, Philadelphia pp. 192-193
21. Kaur K., and Kim K. Int. J. Pharm. 366 (2009) 140